Transvaginal color flow imaging in the diagnosis of ovarian tumors. 1995

R Tepper, and L Lerner-Geva, and M M Altaras, and S Goldberger, and G Ben-Baruch, and S Markov, and I Cohen, and Y Beyth
Department of Obstetrics and Gynecology, Sapir Medical Center, Kfar Saba, Israel.

Transvaginal ultrasonography and color flow imaging, performed to investigate whether there is any diagnostic advantage, were assessed over a 3 year period in 217 patients with adnexal masses prior to explorative laparotomy. Gray scale sonography and color Doppler flow were performed 1 day prior to surgery. Benign tumors were found in 165 patients and flow was detectable in 82 (49.7%); 14 patients had tumors of low malignant potential, 12 (85.7%) of whom showed detectable flow, and 38 had malignant tumors, in 25 (65.8%) of whom flow was detectable. Blood flow velocity was evaluated by the calculation of the resistance index prior to surgery. Mean resistive index was 0.39 +/- 0.05 for malignant tumors, compared with 0.49 +/- 0.06 and 0.55 +/- 0.07 for the low malignant potential and benign tumors, respectively. These differences were statistically significant (P < 0.01). When a resistive index of 0.47 was considered the cut-off value, the sensitivity was 88% and the specificity was calculated to be 85% (using color Doppler flow as the only diagnostic method). With our large cohort of patients, we demonstration the contribution of color Doppler flow examination in differentiating benign from malignant ovarian tumors prior to surgery.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Tepper, and L Lerner-Geva, and M M Altaras, and S Goldberger, and G Ben-Baruch, and S Markov, and I Cohen, and Y Beyth
February 1992, Rinsho byori. The Japanese journal of clinical pathology,
R Tepper, and L Lerner-Geva, and M M Altaras, and S Goldberger, and G Ben-Baruch, and S Markov, and I Cohen, and Y Beyth
July 1992, Obstetrics and gynecology,
R Tepper, and L Lerner-Geva, and M M Altaras, and S Goldberger, and G Ben-Baruch, and S Markov, and I Cohen, and Y Beyth
February 1992, Obstetrics and gynecology,
R Tepper, and L Lerner-Geva, and M M Altaras, and S Goldberger, and G Ben-Baruch, and S Markov, and I Cohen, and Y Beyth
February 1992, Obstetrics and gynecology,
R Tepper, and L Lerner-Geva, and M M Altaras, and S Goldberger, and G Ben-Baruch, and S Markov, and I Cohen, and Y Beyth
November 2004, Ai zheng = Aizheng = Chinese journal of cancer,
R Tepper, and L Lerner-Geva, and M M Altaras, and S Goldberger, and G Ben-Baruch, and S Markov, and I Cohen, and Y Beyth
January 1992, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology,
R Tepper, and L Lerner-Geva, and M M Altaras, and S Goldberger, and G Ben-Baruch, and S Markov, and I Cohen, and Y Beyth
August 1994, Gynecologic oncology,
R Tepper, and L Lerner-Geva, and M M Altaras, and S Goldberger, and G Ben-Baruch, and S Markov, and I Cohen, and Y Beyth
December 1993, American journal of obstetrics and gynecology,
R Tepper, and L Lerner-Geva, and M M Altaras, and S Goldberger, and G Ben-Baruch, and S Markov, and I Cohen, and Y Beyth
April 1994, Geburtshilfe und Frauenheilkunde,
R Tepper, and L Lerner-Geva, and M M Altaras, and S Goldberger, and G Ben-Baruch, and S Markov, and I Cohen, and Y Beyth
April 1996, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology,
Copied contents to your clipboard!